申请人:——
                            
                            
                                公开号:US20040024066A1
                            
                            
                                公开(公告)日:2004-02-05
                            
                            Compounds of formula (I):
1
R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and
R
1
is bicyclyl or heterobicyclyl, are useful in the treatment and prophylaxis of conditions mediated by s-CD23.
                            式(I)的化合物:1R是氢,烷基,烯基,炔基,芳基,杂芳基或杂环烷基;和R1是双环烷基或杂双环烷基,对由s-CD23介导的疾病的治疗和预防具有用处。